What is the history of Recordati?
Recordati S.p.A. was founded in 1926 by Giovanni Recordati in Correggio, Italy, initially starting as a small pharmaceutical laboratory dedicated to researching and manufacturing medicinal preparations. Over subsequent decades, the enterprise expanded its scientific research capabilities, chemical manufacturing infrastructure, and international distribution networks, transforming into a prominent specialty pharmaceutical group. Recordati focused its corporate strategy on acquiring and developing rare disease treatments, prescription pharmaceuticals, and over-the-counter health products. Listed on the Borsa Italiana, the company grew into a major multinational healthcare enterprise operating across Europe, the Americas, and global markets.
Related FAQs
Recordati's corporate mission focuses on reducing the severe impact of rare and devastating diseases by discovering, developing, and providing urgently needed specialty medicines in key therapeutic areas.
Recordati S.p.A.
The global pharmaceutical market features blockbuster medications that generate tens of billions of dollars in annual sales revenue driven by high patient demand and broad therapeutic indications.
Recordati S.p.A.
Recordati S.p.A.
Recordati S.p.A. is an international pharmaceutical group headquartered in Milan, Italy, dedicated to the research, development, manufacturing, and commercialization of specialized healthcare products.
Recordati S.p.A. generates annual consolidated net revenues exceeding €2.2 billion to over €2.4 billion (translating to multi-billion-euro financial metrics), confirming its prominent standing as an international specialty pharmaceutical group.
Recordati Industria Chimica e Farmaceutica S.p.A., an international pharmaceutical group listed on the Borsa Italiana, maintains a market capitalization fluctuating around €10.4 billion to €10.6 billion (equivalent to approximately ₹1.
Interest rates provided by the Bank of Mauston fluctuate according to specific deposit product tiers, compounding schedules, and prevailing monetary policy adjustments set by central banking authorities.
Recordati S.p.A. is an international pharmaceutical enterprise specializing in rare diseases, specialty primary care medications, and orphan drugs.
The Menarini Group, headquartered in Florence, is recognized as the largest Italian pharmaceutical company and a major global healthcare enterprise.